Jyotsna Garg
About
Jyotsna Garg is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery.
According to data from OpenAlex, Jyotsna Garg has authored 23 papers receiving a total of 10.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 5 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Surgery. Recurrent topics in Jyotsna Garg's work include Cardiovascular Function and Risk Factors (5 papers), Heart Failure Treatment and Management (5 papers) and Erythropoietin and Anemia Treatment (4 papers). Jyotsna Garg is often cited by papers focused on Cardiovascular Function and Risk Factors (5 papers), Heart Failure Treatment and Management (5 papers) and Erythropoietin and Anemia Treatment (4 papers). Jyotsna Garg collaborates with scholars based in United States, Canada and Australia. Jyotsna Garg's co-authors include Kenneth W. Mahaffey, Christopher C. Nessel, Graeme J. Hankey, Daniel E. Singer, Guohua Pan, Robert M. Califf, Manesh R. Patel, John F. Paolini, Werner Hacke and Keith A.A. Fox and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of the American College of Cardiology.
In The Last Decade
Jyotsna Garg
20 papers receiving 9.7k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Jyotsna Garg United States | 14 | 7.0k | 3.2k | 2.0k | 1.8k | 1.2k | 23 | 10.0k | ||
| Pieter W. Kamphuisen Netherlands | 57 | 5.4k 0.8× | 6.5k 2.1× | 432 0.2× | 1.3k 0.7× | 1.9k 1.5× | 230 | 10.9k | ||
| Christian T. Ruff United States | 44 | 9.3k 1.3× | 3.3k 1.0× | 4.3k 2.1× | 1.7k 1.0× | 2.6k 2.1× | 175 | 14.5k | ||
| John F. Paolini United States | 32 | 8.1k 1.1× | 3.8k 1.2× | 627 0.3× | 1.6k 0.9× | 1.3k 1.1× | 90 | 10.5k | ||
| Alessandro Squizzato Italy | 42 | 2.1k 0.3× | 2.5k 0.8× | 625 0.3× | 962 0.5× | 1.2k 1.0× | 184 | 5.7k | ||
| Alexander T. Cohen United Kingdom | 43 | 6.8k 1.0× | 8.2k 2.6× | 176 0.1× | 907 0.5× | 2.4k 1.9× | 216 | 10.2k | ||
| Jun Zhu China | 28 | 9.9k 1.4× | 4.0k 1.3× | 424 0.2× | 1.7k 0.9× | 1.0k 0.9× | 133 | 11.3k | ||
| Diana Bonderman Austria | 41 | 5.3k 0.8× | 982 0.3× | 236 0.1× | 945 0.5× | 1.1k 0.9× | 155 | 8.6k | ||
| Barbara A. Hutten Netherlands | 51 | 3.9k 0.6× | 1.9k 0.6× | 2.6k 1.3× | 657 0.4× | 5.3k 4.3× | 215 | 10.3k | ||
| Elvira Grandone Italy | 41 | 1.6k 0.2× | 1.5k 0.5× | 435 0.2× | 732 0.4× | 901 0.7× | 226 | 6.5k | ||
| Alexander Parkhomenko United States | 26 | 6.4k 0.9× | 1.6k 0.5× | 878 0.4× | 821 0.5× | 883 0.7× | 83 | 8.0k |
Countries citing papers authored by Jyotsna Garg
Since
Specialization
Citations
This map shows the geographic impact of Jyotsna Garg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jyotsna Garg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jyotsna Garg more than expected).
Fields of papers citing papers by Jyotsna Garg
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Jyotsna Garg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jyotsna Garg. The network helps show where Jyotsna Garg may publish in the future.
Co-authorship network of co-authors of Jyotsna Garg
This figure shows the co-authorship network connecting the top 25 collaborators of Jyotsna Garg. A scholar is included among the top collaborators of Jyotsna Garg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jyotsna Garg. Jyotsna Garg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Garg, Jyotsna, Frank W. Rockhold, Carmine G. De Pasquale, et al.. (2024). Characterization of Serum Phosphate Levels Over Time with Intravenous Ferric Carboxymaltose Versus Placebo as Treatment for Heart Failure with Reduced Ejection Fraction and Iron Deficiency: An Exploratory Prospective Substudy From HEART-FID. European Journal of Heart Failure. 27(5). 872–880.
2.
Harrington, Josephine, Robert J. Mentz, Frank W. Rockhold, et al.. (2024). Hierarchical End Points in Prior Heart Failure Trials and the HEART-FID Trial. Circulation Heart Failure. 17(2). e010676–e010676.
3.
Mentz, Robert J., Jyotsna Garg, Frank W. Rockhold, et al.. (2023). Ferric Carboxymaltose in Heart Failure with Iron Deficiency. New England Journal of Medicine. 389(11). 975–986.
4.
Harrington, Josephine, Robert J. Mentz, Frank W. Rockhold, et al.. (2023). Baseline characteristics of patients in the randomized study to investigate the efficacy and safety of ferric carboxymaltose as treatment for heart failure with iron deficiency: HEART-FID trial. American Heart Journal. 266. 25–31.
5.
Pencina, Michael, Jennifer B. Green, Keith D. Kaufman, et al.. (2021). Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes. UNC Libraries.
6.
Engelhard, Matthew, Samuel I. Berchuck, Jyotsna Garg, et al.. (2021). Patterns of Health Services Use Before Age 1 in Children Later Diagnosed With ADHD. Journal of Attention Disorders. 25(12). 1639–1639.
7.
Engelhard, Matthew, Samuel I. Berchuck, Jyotsna Garg, et al.. (2020). Health system utilization before age 1 among children later diagnosed with autism or ADHD. Scientific Reports. 10(1). 17677–17677.
8.
Koglin, Joerg, Frans Van de Werf, Eberhard Standl, et al.. (2020). Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus: Secondary Analysis of a Randomized Clinical Trial. UNC Libraries.
9.
McGuire, Darren K., Frans Van de Werf, Paul W. Armstrong, et al.. (2016). Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus. JAMA Cardiology. 1(2). 126–126.
10.
Green, Jennifer B., M. Angelyn Bethel, Paul W. Armstrong, et al.. (2015). Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes. New England Journal of Medicine. 373(3). 232–242.
11.
Afdhal, Nezam H., Bruce R. Bacon, Keyur Patel, et al.. (2014). Accuracy of Fibroscan, Compared With Histology, in Analysis of Liver Fibrosis in Patients With Hepatitis B or C: A United States Multicenter Study. Clinical Gastroenterology and Hepatology. 13(4). 772–779.e3.
12.
Patel, Manesh R., Kenneth W. Mahaffey, Jyotsna Garg, et al.. (2011). Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation. New England Journal of Medicine. 365(10). 883–891.
13.
Kandzari, David E., Sunil V. Rao, Jeffrey W. Moses, et al.. (2009). Clinical and Angiographic Outcomes With Sirolimus-Eluting Stents in Total Coronary Occlusions. JACC: Cardiovascular Interventions. 2(2). 97–106.
14.
Krucoff, Mitchell W., Dean J. Kereiakes, John L. Petersen, et al.. (2008). A Novel Bioresorbable Polymer Paclitaxel-Eluting Stent for the Treatment of Single and Multivessel Coronary Disease. Journal of the American College of Cardiology. 51(16). 1543–1552.
15.
Goyal, Abhinav, Kenneth W. Mahaffey, Jyotsna Garg, et al.. (2006). Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study. European Heart Journal. 27(11). 1289–1297.
16.
Echols, Melvin R., G. Michael Felker, Kevin L. Thomas, et al.. (2006). Racial Differences in the Characteristics of Patients Admitted for Acute Decompensated Heart Failure and Their Relation to Outcomes: Results From the OPTIME-CHF Trial. Journal of Cardiac Failure. 12(9). 684–688.
17.
Mehta, Rajendra H., Robert M. Califf, Jyotsna Garg, et al.. (2005). Association of Height With Outcomes in Patients With Acute Myocardial Infarction Receiving Reperfusion Therapy. The American Journal of Cardiology. 95(11). 1371–1375.
18.
Barbagelata, Alejandro, Marcelo F. Di Carli, Robert M. Califf, et al.. (2005). Electrocardiographic infarct size assessment after thrombolysis: Insights from the Acute Myocardial Infarction STudy ADenosine (AMISTAD) trial. American Heart Journal. 150(4). 659–665.
19.
Sinnaeve, Peter, John Simes, Salim Yusuf, et al.. (2005). Direct thrombin inhibitors in acute coronary syndromes: effect in patients undergoing early percutaneous coronary intervention. European Heart Journal. 26(22). 2396–2403.
20.
Mahaffey, Kenneth W., Marc Cohen, Jyotsna Garg, et al.. (2005). High-Risk Patients With Acute Coronary Syndromes Treated With Low-Molecular-Weight or Unfractionated Heparin. JAMA. 294(20). 2594–2594.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Pieter W. Kamphuisen Breakdown of academic impact, for papers by Christian T. Ruff Breakdown of academic impact, for papers by John F. Paolini Breakdown of academic impact, for papers by Alessandro Squizzato Breakdown of academic impact, for papers by Alexander T. Cohen Breakdown of academic impact, for papers by Jun Zhu Breakdown of academic impact, for papers by Diana Bonderman Breakdown of academic impact, for papers by Barbara A. Hutten Breakdown of academic impact, for papers by Elvira Grandone Breakdown of academic impact, for papers by Alexander Parkhomenko